These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients. Maninder J; Usha A J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155 [TBL] [Abstract][Full Text] [Related]
8. Fluconazole-resistant pseudomembranous oral candidiasis. Shetty K Ann Pharmacother; 2006 May; 40(5):993. PubMed ID: 16638917 [No Abstract] [Full Text] [Related]
9. Molecular characterization of fluconazole resistance in a case of Candida albicans ocular infection. Pancholi P; Park S; Perlin D; Kubin C; Della-Latta P J Clin Microbiol; 2004 Dec; 42(12):5938-9. PubMed ID: 15583347 [TBL] [Abstract][Full Text] [Related]
10. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest]. Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812 [TBL] [Abstract][Full Text] [Related]
11. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients. Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689 [TBL] [Abstract][Full Text] [Related]
12. Susceptibility of candida isolates from denture-related stomatitis to antifungal agents in vitro. Dorocka-Bobkowska B; Konopka K Int J Prosthodont; 2007; 20(5):504-6. PubMed ID: 17944341 [TBL] [Abstract][Full Text] [Related]
13. Vulvovaginal candidiasis in a Flemish patient population. De Vos MM; Cuenca-Estrella M; Boekhout T; Theelen B; Matthijs N; Bauters T; Nailis H; Dhont MA; Rodriguez-Tudela JL; Nelis HJ Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555 [TBL] [Abstract][Full Text] [Related]
14. Fluconazole resistance in Candida albicans: a review of mechanisms. Casalinuovo IA; Di Francesco P; Garaci E Eur Rev Med Pharmacol Sci; 2004; 8(2):69-77. PubMed ID: 15267120 [TBL] [Abstract][Full Text] [Related]
16. Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicentre study. Lee MK; Kim HR; Kang JO; Kim MN; Kim EC; Kim JS; Kim JJ; Park YJ; Song W; Shin JH; Lee KM; Lee NY; Lee M; Lee WG; Lee CK; Lee HJ; Chang CL; Choi TY Mycoses; 2007 Mar; 50(2):148-9. PubMed ID: 17305780 [TBL] [Abstract][Full Text] [Related]
17. No resistance to fluconazole with short-term treatment for oral thursh. AIDS Patient Care STDS; 1996 Dec; 10(6):379. PubMed ID: 11361570 [No Abstract] [Full Text] [Related]
18. Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy. Shahid Z; Sobel JD Diagn Microbiol Infect Dis; 2009 Jul; 64(3):354-6. PubMed ID: 19501794 [TBL] [Abstract][Full Text] [Related]
19. Relationship between fluconazole dosage regimens and the emergence of fluconazole-resistant Candida albicans. Goetz MB AIDS; 1996 Mar; 10(3):335-6. PubMed ID: 8882674 [No Abstract] [Full Text] [Related]
20. Correlation between adhesion, enzyme production, and susceptibility to fluconazole in Candida albicans obtained from denture wearers. Lyon JP; de Resende MA Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Nov; 102(5):632-8. PubMed ID: 17052640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]